Drug Shortage Report for ACT CABERGOLINE

Last updated on 2017-10-05 History
Report ID 8767
Drug Identification Number 02301407
Brand name ACT CABERGOLINE
Common or Proper name CABERGOLINE
Company Name TEVA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) CABERGOLINE
Strength(s) 0.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 8
ATC code G02CB
ATC description OTHER GYNECOLOGICALS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2015-01-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-05-03 French Compare
v1 2017-05-03 English Compare

Showing 1 to 2 of 2